Hepatitis C, Transjugular Intrahepatic PortosystemicShunt Versus Endoscopic Sclerotherapy for the Prevention ofVariceal Bleeding in Cirrhosis: A Randomized MulticenterTrial | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search

Figure1

Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Sclerotherapy for the Prevention of Variceal Bleeding in Cirrhosis: A Randomized Multicenter Trial

Fig. 1. Cumulative proportion (Kaplan-Meier plot) of patients free of rebleeding.

Return To Article

Table Of Contents